Sleep disordered breathing diseases have become a major public health and social problem in modern society. Sleep disordered breathing diseases represented by obstructive sleep apnea hypoventilation syndrome (OSAHS) and upper airway resistance syndrome account for 38% of pathological sleep disorders, and it has been confirmed that OSAHS is an independent risk factor for hypertension, coronary heart disease, cerebrovascular disease, diabetes mellitus, Alzheimer’s disease and other diseases, and its coexistence with metabolic syndrome can be up to 20%. Surgical treatment of OSAHS is no longer limited to patients who are intolerant to continuous positive pressure ventilation therapy (CPAP) on ventilators, and the success of surgical procedures has made surgery an appropriate treatment option for OSAHS. Only about 20-25% of OSAHS patients have simple palatopharyngeal plane stenosis. Patients with OSAHS tend to have obesity and a short thick neck, often combined with submucosal adipose tissue accumulation in the hypopharynx resulting in narrowing of the airway in the lingual-pharyngeal plane. More than 90% have tongue hypertrophy. Tongue plasma perforation ablation (CCT), with the advantages of less bleeding, less injury, shorter operation time, quick recovery and repeatable operation, is the best treatment method for tongue hypertrophy. It is recommended for snoring patients.